{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:23Z","timestamp":1791996083294,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:00:00Z","timestamp":1698451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00228-023-03585-2","type":"journal-article","created":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T15:01:41Z","timestamp":1698505301000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Retrospective review of intermittent and continuous infusion vancomycin for methicillin-resistant Staphylococcus aureus bacteremia"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-9770","authenticated-orcid":false,"given":"Diari","family":"Gilliam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1656-9050","authenticated-orcid":false,"given":"Dominic","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-5062","authenticated-orcid":false,"given":"Martha L.","family":"Carvour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1367-6048","authenticated-orcid":false,"given":"Carla","family":"Walraven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"issue":"3","key":"3585_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1086\/600877","volume":"49","author":"MJ Rybak","year":"2009","unstructured":"Rybak MJ, Lomaestro BM, Rotscahfer JC et al (2009) Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49(3):325\u2013327. https:\/\/doi.org\/10.1086\/600877","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3585_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP et al (2020) Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 77(11):835\u2013864. https:\/\/doi.org\/10.1093\/ajhp\/zxaa036","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"3585_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijantimicag.2015.10.019","volume":"47","author":"J-J Hao","year":"2016","unstructured":"Hao J-J, Chen H, Zhou J-X (2016) Continuous versus intermittent infusion of vancomycin in adult patients: a systematic review and meta-analysis. Int J Antimicrob Agents 47(1):28\u201335. https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.10.019","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"3585_CR4","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1128\/AAC.45.9.2460-2467.2001","volume":"45","author":"M Wysocki","year":"2001","unstructured":"Wysocki M, Delatour F, Faurisson F et al (2001) Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 45(9):2460\u20132467. https:\/\/doi.org\/10.1128\/AAC.45.9.2460-2467.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"3585_CR5","doi-asserted-by":"publisher","unstructured":"Schlobohm CJ, Zhu E, Duby JJ (2021) Continuous Infusion versus Intermittent Infusion Vancomycin in a Burn Center Intensive Care Unit.\u00a0Burns 47(7):1495\u20131501. https:\/\/doi.org\/10.1016\/j.burns.2021.08.016","DOI":"10.1016\/j.burns.2021.08.016"},{"key":"3585_CR6","doi-asserted-by":"publisher","unstructured":"Flannery AH, Bissell BD, Bastin MT, Morris PE, Neyra JA (2020) Continuous versus intermittent infusion of vancomycin and the risk of acute kidney injury in critically ill adults: a systematic review and meta-analysis.\u00a0Crit Care Med\u00a048(6):912\u201318. https:\/\/doi.org\/10.1097\/CCM.0000000000004326","DOI":"10.1097\/CCM.0000000000004326"},{"key":"3585_CR7","doi-asserted-by":"publisher","unstructured":"Singbartl K, Kellum JA (2012) AKI in the ICU: definition, epidemiology, risk stratification, and outcomes.\u00a0Kidney Int\u00a081(9):819\u201325. https:\/\/doi.org\/10.1038\/ki.2011.339","DOI":"10.1038\/ki.2011.339"},{"key":"3585_CR8","doi-asserted-by":"publisher","unstructured":"Neely MN, Kato L, Youn G, Kraler L, Bayard D, van Guilder M, Schumitzky A, Yamada W, Jones B, Minejima E (2018) Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing.\u00a0AntimicrobAgents Chemother\u00a062(2):e02042\u201317. https:\/\/doi.org\/10.1128\/AAC.02042-17","DOI":"10.1128\/AAC.02042-17"},{"issue":"9","key":"3585_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1164\/rccm.201311-2097OC","volume":"189","author":"A Linder","year":"2014","unstructured":"Linder A, Fjell C, Levin A, Walley KR, Russell JA, Boyd JH (2014) Small acute increases in serum creatinine are associated with decreased long-term survival in the critically ill. Am J Respir Crit Care Med 189(9):1075\u20131081. https:\/\/doi.org\/10.1164\/rccm.201311-2097OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3585_CR10","doi-asserted-by":"publisher","unstructured":"Spapen HD, Janssen van Doorn K, Diltoer M, Verbrugghe W, Jacobs R, Dobbeleir N, Honor\u00e9 PM, Jorens PG (2011) Retrospective evaluation of possible renal toxicity associated with continuous infusion of vancomycin in critically ill patients.\u00a0Ann Intensive Care 1(1):26. https:\/\/doi.org\/10.1186\/2110-5820-1-26","DOI":"10.1186\/2110-5820-1-26"},{"key":"3585_CR11","doi-asserted-by":"publisher","unstructured":"Cianferoni S, Devigili A, Ocampos-Martinez E, Penaccini L, Scolletta S, Abdelhadii A, De Backer D et al (2013) Development of acute kidney injury during continuous infusion of vancomycin in septic patients.\u00a0Infection 41(4):811\u201320. https:\/\/doi.org\/10.1007\/s15010-013-0460-9","DOI":"10.1007\/s15010-013-0460-9"},{"key":"3585_CR12","doi-asserted-by":"publisher","unstructured":"Hutschala D, Kinstner C, Skhirdladze K, Thalhammer F, M\u00fcller M, Tschernko E (2009) Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.\u00a0Anesthesiology 111(2):356\u201365. https:\/\/doi.org\/10.1097\/ALN.0b013e3181a97272","DOI":"10.1097\/ALN.0b013e3181a97272"},{"key":"3585_CR13","doi-asserted-by":"publisher","unstructured":"Ray AS, Haikal A, Hammoud KA, Alan SL (2016) Vancomycin and the risk of AKI: a systematic review and meta-analysis.\u00a0Clin J Am Soc Nephrol CJASN 11(12):2132\u201340. https:\/\/doi.org\/10.2215\/CJN.05920616","DOI":"10.2215\/CJN.05920616"},{"key":"3585_CR14","doi-asserted-by":"publisher","unstructured":"Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S\u00a0(2013) Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study.\u00a0BMJ (Clinical Research Ed.) 346:e8525. https:\/\/doi.org\/10.1136\/bmj.e8525","DOI":"10.1136\/bmj.e8525"},{"key":"3585_CR15","doi-asserted-by":"publisher","unstructured":"van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.\u00a0Antimicrob Agents Chemother\u00a057(2):734\u201344. https:\/\/doi.org\/10.1128\/AAC.01568-12","DOI":"10.1128\/AAC.01568-12"},{"key":"3585_CR16","doi-asserted-by":"publisher","unstructured":"Jorgensen SC, Murray KP, Lagnf AM, Melvin S, Bhatia S, Shamim MD, Smith JR et al (2020) A multicenter evaluation of vancomycin-associated acute kidney injury in hospitalized patients with acute bacterial skin and skin structure infections.\u00a0Infect Dis Ther\u00a09(1):89\u2013106. https:\/\/doi.org\/10.1007\/s40121-019-00278-1","DOI":"10.1007\/s40121-019-00278-1"},{"issue":"3","key":"3585_CR17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/cpt.726","volume":"102","author":"EJ Filippone","year":"2017","unstructured":"Filippone EJ, Kraft WK, Farber JL (2017) The nephrotoxicity of vancomycin. Clin Pharmacol Ther 102(3):459\u2013469. https:\/\/doi.org\/10.1002\/cpt.726","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"3585_CR18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s00134-022-06811-0","volume":"48","author":"TA Miano","year":"2022","unstructured":"Miano TA, Hennessy S, Yang W et al (2022) Association of vancomycin plus piperacillin\u2013tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study. Intensive Care Med 48(9):1144\u20131155. https:\/\/doi.org\/10.1007\/s00134-022-06811-0","journal-title":"Intensive Care Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03585-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T07:02:48Z","timestamp":1704870168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03585-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,28]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3585"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03585-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,28]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This protocol was approved by the Institutional Review Board (STUDY00005330), and the requirement for patient consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}